BNP Paribas Financial Markets
BRLI

BNP Paribas Financial Markets’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

BNP Paribas Financial Markets’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,431
Closed -$100K – 3751
2015
Q2 		$100K Buy
2,431
+1,852
+320% +$66.4K ﹤0.01% 2079
2015
Q1 		$20.4K Buy
579
+379
+190% +$12.8K ﹤0.01% 2356
2014
Q4 		$6.43K Sell
200
-1,444
-88% -$41.8K ﹤0.01% 1808
2014
Q3 		$46.1K Buy
1,644
+1,606
+4,226% +$48.9K ﹤0.01% 2647
2014
Q2 		$1.15K Buy
+38
New +$1.05K ﹤0.01% 3392
2014
Q1 		– Sell
-317
Closed -$8.1K – 4139
2013
Q4 		$8.1K Buy
+317
New +$9.77K ﹤0.01% 2781
2013
Q3 		– Sell
-8,338
Closed -$240K – 2837
2013
Q2 		$240K Buy
+8,338
New +$230K ﹤0.01% 2192

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

BNP Paribas Financial Markets's BRLI Position: Q3 2015 in Review

BNP Paribas Financial Markets sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 2,431 shares — an estimated $100K sold.

BNP Paribas Financial Markets first reported a position in BRLI in Q2 2013 and held it in 7 quarters. The position peaked at $240K in Q2 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • BNP Paribas Financial Markets reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2,431 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $100K.
  • BNP Paribas Financial Markets first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 7 quarters.
  • BNP Paribas Financial Markets's BIO-REFERENCE LABS INC-NEW- position peaked at $240K in Q2 2013.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2015, filed 13 Nov 2015.